Hari et al. Is the international staging system superior to the durie-salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia 23:1528-1534, 2009. http://www.nature.com/leu/journal/v23/n8/full/leu200961a.html
Ballester et al. Hematopoietic stem cell transplantation in the elderly. Oncology (Williston Park) 2007;21:1576-1583; discussion 1587, 1590–1591, 1606, 2007. http://www.ncbi.nlm.nih.gov/pubmed?term=18179047
Einsele et al.: Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning. Brit J Haemat 2003;121:411-418, 2003.http://www.ncbi.nlm.nih.gov/pubmed?term=12716363
Miguel et al. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial. Lancet Oncol. 2013 Oct;14(11):1055-66. doi: 10.1016/S1470-2045(13)70380-2. Epub 2013 Sep 3. http://www.ncbi.nlm.nih.gov/pubmed/24007748